Orgenesis Inc. - stock earnings
ORGS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 9, 2024 BeforeMarket | - / 0.0408000000 | - | - / 12.2 million | - |
ORGS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -4.1 million USD | 7.0 million USD |
| 2022Q4 | -4.1 million USD | 13.6 million USD |
| 2022Q3 | -1.4 million USD | 8.0 million USD |
| 2022Q2 | -5.4 million USD | 7.2 million USD |
| 2022Q1 | -4.0 million USD | 7.2 million USD |
| 2021Q4 | -5.0 million USD | 6.9 million USD |
| 2021Q3 | -10.2 million USD | 8.7 million USD |
| 2021Q2 | -2.7 million USD | 10.5 million USD |
| 2021Q1 | -219000 USD | 9.4 million USD |
| 2020Q4 | -51.6 million USD | 2.3 million USD |
| 2020Q3 | -2.4 million USD | 1.7 million USD |
ORGS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -25.1 million USD | 27.8 million USD |
| 2022 | -12.2 million USD | 36.0 million USD |
| 2021 | -18.1 million USD | 35.5 million USD |
| 2020 | -95.1 million USD | 7.7 million USD |
| 2019 | -26.0 million USD | 33.3 million USD |
| 2018 | -18.3 million USD | 18.7 million USD |
| 2017 | -12.4 million USD | 10.1 million USD |
| 2016 | -9.2 million USD | 6.4 million USD |
| 2015 | -4.5 million USD | 3.0 million USD |
| 2014 | -5.5 million USD | ? USD |
| 2013 | -5.5 million USD | ? USD |
| 2012 | -5.0 million USD | ? USD |
| 2011 | -72352 USD | ? USD |
| 2010 | -36173 USD | ? USD |
| 2009 | -25648 USD | ? USD |
| 2008 | -3500 USD | ? USD |
ORGS
Price: $0.53
52 week price:
Earnings Per Share: -1.91 USD
P/E Ratio: -0.34
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 23800
Market Capitalization: 17.9 million